Alphamab Oncology (HKG:9966)

Hong Kong · Delayed Price · Currency is HKD

7.85

+0.06 (0.77%)

Mar 6, 2026, 4:08 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Pharmaceuticals	640.08M	218.77M	166.85M	146.02M		4.99M
Pharmaceuticals Growth	192.58%	31.12%	14.26%	-		-
Total	640.08M	218.77M	166.85M	146.02M		4.99M
Total Growth	192.58%	31.12%	14.26%	-		-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
People's Republic of China ("PRC")	640.08M	218.77M	166.85M	146.02M		4.99M
People's Republic of China ("PRC") Growth	192.58%	31.12%	14.26%	-		-
Total	640.08M	218.77M	166.85M	146.02M		4.99M
Total Growth	192.58%	31.12%	14.26%	-		-

Source: S&P Global Market Intelligence.